ACE |
angiotensin-converting enzyme |
ACEI |
angiotensin-converting enzyme inhibitor |
ACE2 |
angiotensin-converting enzyme 2 |
ADAM17 |
tumor necrosis factor-α-converting enzyme (TACE) |
Ac-SDKP |
N-acetyl-seryl-aspartyl-lysyl-proline |
Ang 1-7 |
angiotensin-(1-7) |
Ang 1-9 |
angiotensin-(1-9) |
Ang II |
angiotensin II; |
Ang III |
angiotensin III |
Ang IV |
angiotensin IV |
APA |
aminopeptidase A |
APM |
aminopeptidase M |
ARB |
angiotensin II type 1 receptor blocker |
ARDS |
acute respiratory distress syndrome |
AT1R |
angiotensin II type 1 receptor |
AT2R |
angiotensin II type 2 receptor |
C21 |
compound 21 |
COVID-19 |
coronavirus disease 2019 |
DABK |
des-Arg9-bradykinin |
Mas |
receptor Mas |
mACE2 |
membrane-bound angiotensin-converting enzyme 2 |
sACE2 |
soluble angiotensin-converting enzyme 2 |
MrgD |
Mas-related G-protein coupled receptor member D |
RAAS |
renin–angiotensin–aldosterone system |
rhACE2 |
recombinant human angiotensin-converting enzyme 2 |
SARS-CoV |
severe acute respiratory syndrome coronavirus |
SARS-CoV-2 |
severe acute respiratory syndrome coronavirus 2 |
TNFα |
tumor necrosis factor α |
TMPRSS2 |
transmembrane protease serine 2 |